Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phrontline Biopharma

Clinical trials sponsored by Phrontline Biopharma, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New cancer drug TJ101 enters first human trials for advanced tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New cancer drug TJ101 enters first human trials for advanced tumors

Disease control Recruiting now

This Phase 1 trial is testing TJ101, an experimental antibody-drug conjugate that delivers chemotherapy directly to cancer cells. It is for adults with advanced or metastatic solid tumors (lung, prostate, esophageal, and others) who have run out of standard options. The study aim…

Phase 1 • Sponsor: Phrontline Biopharma • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC